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Summary Cell fusion has been used to analyse the genetic determinants of metastasis at the cellular level.
Highly metastatic mouse melanoma cells were fused with diploid mouse lymphocytes and a range of hybrid
clones isolated and tested for tumorigenicity and metastatic potential by s.c. injection into newborn,
histocompatible, sublethally-irradiated mice. Although almost all clones tested were tumorigenic, most had
considerably reduced metastatic potential. This suggests that tumorigenicity and metastasis are determined by
different genetic elements. Histological examination of primary tumours produced by metastatic and non-
metastatic hybrid cell lines showed that an essential step in the production of metastases is the separation of
tumour cells from the main tumour mass and their movement into the surrounding tissues. The primary
tumours of a metastatic hybrid cell line showed local invasiveness whereas those of a non-metastatic cell line
did not.
Although progressive growth is the property of
tumour cells that has attracted most research effort,
the properties that menace the life of a tumour-
bearing host are invasiveness and the ability of the
cells to establish distant metastases. The fact that,
until recently, comparatively little effort had been
devoted to the experimental investigation of
invasion and metastasis reflects the difficulty of
planning and carrying out informative experiments
in this field. The situation is now changing, and
experimental systems yielding interesting and
important results have been introduced (Fidler,
1973; Nicolson & Winkelhake, 1975; Fidler &
Kripke, 1977; Mareel et al., 1979; Tao & Burger,
1977; Giavazzi et al., 1980; Poste et al., 1980).
One of the dilemmas in the investigation of
metastasis is whether to treat the phenomenon as a
single process or to break it down into its
constituent parts and examine each separately. The
overall process of metastasis is often divided into
several stages. These usually include: 1) escape of
cells from the primary tumour, 2) penetration of
blood vessels, lymphatics or other channels of
communication, 3) transport of cells via these
routes, 4) arrest of circulating cells and their
implantation on an appropriate surface, 5)
repenetration of blood or lymph vessel walls and 6)
growth of tumour cells at the new secondary site.
Cells that fail to complete any one of these stages
cannot form metastases.
In all the early experiments with the B16
melanoma cell lines the tumour cells were injected
i.v. and metastatic potential was assessed by the
formation of colonies in the lung. This method by-
passes the first three steps of the overall process
described above and measures a property that is
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now more usually referred to as "colonization
potential." It has been shown that cells with a high
colonization potential are not necessarily efficient at
establishing spontaneous metastases after s.c.
injection (Stackpole, 1981; Weiss et al., 1982).
In the work described in the present paper all
tumours were established by s.c. injection and
metastatic potential was measured by observation
of secondary deposits formed spontaneously in the
lungs. All cells giving rise to metastases must
therefore have passed through all the steps
described above. It is clear that the isolation and
characterization of tumour cell variants of different
metastatic potential will be of importance in
uncovering the mechanisms involved in metastasis
(Poste & Fidler, 1980). We show here that cell




Melanoma All the melanoma cell lines were
derived from a spontaneous tumour found in a
C57B1 mouse by Parish and subsequently
introduced by him into this laboratory (Jonasson et
al., 1977). Hypoxanthine-guanine phosphoribosyl
transferase (HPRT-) mutant cell lines were selected
by growing wild type cells in 6-thioguanine
(5ygml-1) after exposing them to ethyl methane
sulphonate, (200 or 300 ugml-1) for 24h. The
thymidine kinase (TK-) mutants were selected after
growth for several generations in 10O pgml-l
bromodeoxyuridine followed by exposure to a
bright white light source for 2 1/4h. The derivation
of the various cell lines, including the mutant cell
lines, the "T" lines and the hybrid cell lines is shown
in Figure 1. Cells were grown routinely in MEM.
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Figure 1 Derivation ofmelanoma, mutant and hybrid
cell lines.
medium (Gibco, Paisley, Scotland) supplemented
with 10% new born calf serum (Gibco, or Sera-Lab.,
Crawley Down, Sussex). All cell lines were screened
periodically for mycoplasma contamination, using
Hoechst 33258 fluorochrome as described by Chen
(1977) and found to be negative.
Lymphocytes The lymphocytes used in the cell
fusions were obtained from teased lymph nodes
excised from young adult CBA mice carrying the
T6T6 translocation.
Cellfusion
This was done essentially as described by Harris &
Watkins (1965) using UV-inactivated Sendai virus
as the fusing agent and a 10:1 lymphocyte
melanoma cell ratio; typically 107 lymphocytes, 106
melanoma cells. The hybrid clones were isolated in
HAT medium (Littlefield, 1964).
Assays oftumorigenicity & metastatic potential
Unless otherwise stated all tests were made by
injecting 5 x 104 cells, in 0.05ml of phosphate-
buffered saline, s.c. into the backs of newborn (< 5
day-old) sublethally-irradiated (4Gy) syngeneic
mice. For tests on hybrid cells the hosts were the
F1 offspring of C57B1/6 x CBA T6T6 matings.
Since in principle the chances of generating
metastases will increase with the duration of
primary tumour growth, the primary tumours were
allowed to grow for as long as was in practice
possible. The animals were sacrificed when death
from the tumour was impending. This end point has
the advantage that it maximizes the probability of
observing metastasis if the inoculum of cells is, in
fact, capable of generating any.
Internal organs were examined for metastases
visible to the naked eye. The lungs were removed,
examined under a dissecting microscope and then
fixed in formal saline and processed for routine
histology. Other organs (liver, lymph nodes, kidney,
spleen) were periodically examined under the
dissecting microscope and by routine histology. In
only a very small number of mice were metastases
found in organs other than the lungs, and all the
data recorded in the present paper refer to lung
metastases. An animal was scored as positive for
metastasis if one or more metastasis was identified
unequivocally either by naked eye, under the
dissecting microscope or in a histological section.
Results
Tumorigenicity & metastatic potential of melanoma
cell lines
Table I gives the tumour take incidence and the
incidence of metastases of the parental tumour cells
and the HPRT- derivatives of them. The parental
tumour cells gave 100% take incidences. Some of
the HPRT- derivatives fell short of this, but the
overall take incidences remained very high. In the
case of metastatic potential, however, selection for
6-thioguanine resistance produced a marked
reduction. All the parental cells gave metastases in
70-80% of inoculated animals. For the HPRT-
derivatives this figure was from 0-40%. It thus
appears that selection for thioguanine resistance
also selects (probably co-incidentally) against
metastatic potential. A cell line, Melgo-1, was
derived from pooled metastatic nodules. This gave a
100% take incidence and a 81% incidence of
metastases. When HPRT- subclones of Melgo-1
were isolated and examined, although the take
incidences remained 100%, the incidence of
metastases varied from 0-77%. This type of
variation in subclones has been described by Poste
et al. (1981), who argue that heterogeneity of the
cell population innoculated is required for the
production of metastases. An equally plausible
explanation is that the cells capable of generating
metastases form only a small minority of the cell
population injected so that individual subclones
would be expected to show large variations in
metastatic potential. One "T" line Melgo-1 6TGCELL FUSION AND METASTATIC POTENTIAL 401
Table I Tumorigenicity & metastasis of melanoma derivatives*
Tumorigenicity* Metastases
no. I' tumours no. with metastases
Cell line no. mice injected no. with I' tumours % Cell line Tumorigenicity Metastases %
Parent cells
MELJO 24/24 19/24 79
MEL 39-1 35/35 26/35 74
MELRU 21/21 15/21 71
MELGO 61/61 50/61 82 Melgo TI 11/11 11/11 100
MELGO-1 21/21 17/21 81
HPRT-
Mutant cells
PG19 29/30 6/29 21
NuP2 16/16 3/16 19
Cl 2C 6/22 0/6 0
Melgo-I 6TG
C1.2 6/6 0/6 0 C1.2 T1 11/11 3/11 27
C1.3 7/7 2/7 29
C1.4 13/13 5/13 39 C1.4 Ti 7/7 2/7 29
C1.5 10/10 3/10 30 C1.5 Ti 14/14 2/14 14
C1.6 8/8 1/8 13
C1.7 7/7 0/7 0
C1.8 11/11 3/11 27 C1.8 T1 35/35 27/35 77
Cl.9 8/9 0/8 0
*All animals were sublethally irradiated syngeneic newborns and were injected with 5 x 104 cells s.c.
C1.8T1, gave a 77% incidence of metastasis and
maintained this high metastatic potential on further
cultivation and subcloning. This "T" line was
therefore used as the parent cell in the cell fusion
experiments.
Tumorigenicity & metastatic potential ofhybrid cells
1. Hybrids between metastatic cells and diploid
lymphocytes Table II gives the incidence of
primary tumours and metastases in a series ofhybrid
clones isolated from a cross between Melgo-1 6TG
C1.8T1 and diploid CBA T6T6 lymphocytes. These
F.87 clones all gave 100% take incidence for
primary tumours but gave a low incidence of
metastases (0-17%) compared with the metastatic
parent cell line (77%). Some of the hybrid clones
and their tumours were examined karyologically by
Dr. E.P. Evans (see Evans et al., 1982 for Methods)
and were shown to be triparental hybrids (2
melanoma x 1 lymphocyte) that had sustained
substantial chromosome losses. It thus appears that
the genetic determinants of progressive growth, as
revealed by the incidence of primary tumours, may
be dissociated, by cell fusion and subsequent
chromosome segregation, from the determinants of
metastasis.
When cells were isolated from primary tumours
and retested no significant increase in metastatic
potential was observed in most of the "T" lines, but
one, F87 Cl 6T2, gave a high incidence of
metastasis and has continued to do so on repeated
cultivation and testing. These results support the
view that cells capable of generating metastases are
present in these cell populations in small numbers
but enrichment for such cells can be achieved by
selective procedures.
F87 Cl. 6T2 cells have a morphology that is
easily distinguishable from the poorly metastatic
lines (e.g. F87 Cl. 4T1). They are currently being
used to study various biological and biochemical
properties that have been postulated by other
workers to be of importance in the production of
metastases.
2. Hybrids between two different tumour cell
lines Weiner et al. (1974) have shown that when
different kinds of tumour cells are fused together,
the resulting hybrids are usually tumorigenic. It was
therefore of interest to examine the consequences of
fusing together two metastatic cell lines. We have
not been able to isolate a thymidine kinase-
variant of the melanoma with a metastatic potential
as high as that of Melgo 1 6TG Cl. 8T1, but402 E. SIDEBOTTOM & S.R. CLARK
Table 11 Tumorigenicity & metastasis ofhybrid clones (Melgo-1 6TG CI.8 Ti x CBA T6T6 lymphocytes) F.87
Tumorigenicity Metastases
no. F tumours no. with metastases
Cell line no. mice injected no. with 1° tumours Cell line Tumorigenicity Metastases
Melanoma
Parent 35/35 27/35
Hybrid F87 Cl.l 9/9 0/9 Cl.l Ti 13/13 0/13
F87 C1.3 11/11 0/11 C1.3 TI 16/16 1/16
F87 C1.4 8/8 0/8 C1.4 TI 37/37 0/37
F87 CI.5 12/12 0/12 C1.5 T2 9/9 2/9
F87 Cl.6 12/12 2/12 C1.6 T1 18/18 10/18
CI.6 T2 77/77 73/77
F87 C1.7 56/56 1/56 CI.7 TI 14/14 4/14
F87 CI.8 15/15 2/15 C1.8 Ti 8/8 0/8
Melgo-1 TK- Cl. 7 gave an incidence of metastases
of between 20 and 30%, and therefore provided an
adequate, if not ideal, parent cell. The results of
tests on F92 hybrid clones derived from the fusion
of Melgo-i 6TG Cl. 8T1 with Melgo-i TK- Cl. 7
are shown in Table III. In agreement with Weiner
et al. (1974), we found that all the hybrid clones
gave a I100% take incidence, like the parent cells.
However, the incidence of metastases was greatly
reduced in the hybrid clones, the majority
producing no metastases at all. This low metastatic
potential was maintained on cells isolated directly
from the primary tumours (the Ti series). These
results provide further evidence that the genetic
determinants of progressive growth can be
segregated by cell fusion from the genetic
determinants of metastasis.
Table III Tumorigenicity & metastasis of hybrid clo
TI x Melgo-l TK- C1.7) F92
Histologicalfindings
We have made a systematic histological
examination of the tumours produced by clones
that generate metastases and those that do not. The
observations will be reported in detail elsewhere,
but the essential features are as follows. The social
behaviour of cells in the primary tumours produced
by metastatic cell lines can be easily distinguished
from that of the cells in the primary tumours
produced by non-metastatic cell lines. In tumours
produced by cell lines that give rise to metastases,
the cells at the periphery of the tumour move away
from the main tumour mass and migrate into the
surrounding tissues (Figure 2). In tumours produced
by cell lines that do not give rise to metastases, the
cells at the periphery of the tumour remain attached
nes between two metastatic cell lines (Melgo-l 6TG C1.8
Tumorigenicity Metastases
no. J° tumours no. with metastases
Cell line no. mice no. with 1 tumours Cell line Tumorigenicity Metastases
Melgo-I
6TG C1.8 TI 35/35 27/35
Melgo-I
TK-Cl 7 19/19 5/19
Hybrid F92 Cl.1 11/12 1/11 Cl.l TI 13/13 0/13
F92 C1.2 17/17 1/17 C1.2 TI 14/14 1/14
F92 C1.3 14/14 2/14 C1.3 TI 9/9 0/9
C1.3 T2 12/12 0/12
F92 C1.4 11/14 0/11 C.4 T1 10/11 0/10
F92 C1.5 11/11 0/11 C1.5 T1 14/14 0/14
F92 C1.6 9/9 1/9 C1.6 T1 15/15 0/15
F92 C1.7 11/11 0/11 C1.7 T1 18/18 0/18
F92 Cl.8 13/13 0/13 C1.8 Tl 13/13 0/13
F92 Cl.9 16/16 0/16
F92 C1.10 16/17 0/16CELL FUSION AND METASTATIC POTENTIAL 403
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Figure 2 Periphery of primary tumours growing in the s.c. tissues of newborn mice after the injection of
5 x 104 F87C16T2-Ifnetastatic cells). (a) 10d after injection. The edge of the tumour is ill-defined and clumps
of-tumorcIls have separated from the main tumour mass (arrows). (b) 7d. Tumour cells are invading
through muscle into the dermis (arrows).
to the main tumour mass (Figure 3) and apparently
do not become disseminated even when the tumour
has grown into the lumen of a vessel (Figure 4).
These findings indicate that an essential element in
the production of spontaneous metastases from a
solid tumour growing in an s.c. site is the extent to
which the cells in the tumour cohere or fail to
cohere. This property must be determined by
genetic elements that are different from those that
determine the progressive growth of the primary
tumour itself.
Discussion
Two simple conclusions can be drawn from the
experiments described here. First it is possible to
make hybrids between malignant and normal cells in
which different hybrid clones vary considerably in
their ability to produce metastases. Second, in these
segregant clones, tumorigenicity and metastatic
potential' are easily dissociated. On the simplest
hypothesis that both tumorgenicity and metastatic
potential are genetically determined the genes
determining the one cannot be closely linked to
those determining the other.
The experiments show further that cell fusion can
be used to analyse metastasis in much the same way
as has been used to analyse progressive growth
(Harris et al., 1969; Harris, 1971, 1975). Since
metastatic potential segregates in hybrid cells,
matched pairs of metastatic and non-metastatic
hybrids can be used to search for biological or
biochemical markers that are linked to the ability of
tumour cells to produce secondary deposits. We
have begun to use such matched pairs of hybrids as
screens for markers linked to metastasis and the
histological difference reported here in the
behaviour of primary tumours derived from
metastatic and non-metastatic hybrid cell lines is an
example of a marker detected in this way.a--.~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.
40~~~~~~~~~~~~~~. ,;f. : &f.g,>A
Figure 4 Clump of F87C14T1 (non-metastatic) cells
within the lumen of a blood vessel in the subcutaneous
tissues of a newborn mouse, 24h after injection.
Figure 3 Periphery of primary tumours growing in
the s.c. tissues of newborn mice 14d after injection
5 x 104 F87C14T1 (non-metastatic) cells. In both
tumours the edge is clearly defined (arrows), no
invasion is seen (a) Pigmented tumour (b)
unpigmented tumour.
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